Research study Program year 2023 Source: CMS Open Payments

A Phase 2, Randomized, Double-Blind, Multi-Dose, Dose Finding Studyto

Research payments

$467,445

51 payments

Through program year 2023, $467,445 in research payments was reported against A Phase 2, Randomized, Double-Blind, Multi-Dose, Dose Finding Studyto, across 51 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$467,445	51

Breakdown

Who paid Research payments · program year 2023

GlaxoSmithKline, LLC. $467,445 51 payments

Who received the money Research payments · program year 2023

Mercury Clinical Research Organisation paid for research $163,778 9 payments
Alliance For Multispecialty Researc Organisation paid for research $76,318 6 payments
Alliance For Multispecialty Research LLC Organisation paid for research $57,397 5 payments
Dynamed Clinical Research LP Organisation paid for research $45,323 3 payments
Sec Clinical Research LLC Organisation paid for research $23,564 3 payments
Dr Shelly David Senders MD INC Organisation paid for research $21,602 3 payments
Tribe Clinical Research Organisation paid for research $21,499 2 payments
Boeson Research LLC Organisation paid for research $20,390 3 payments
Ctr For Clinical Research Organisation paid for research $7,934 3 payments
The Childrens Clinic PA Organisation paid for research $7,597 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.